These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21715725)

  • 1. Risk assessment and prophylaxis for VTE in cancer patients.
    Khorana AA
    J Natl Compr Canc Netw; 2011 Jul; 9(7):789-97. PubMed ID: 21715725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thromboprophylaxis in cancer patients: emerging data.
    Menapace LA; Khorana AA
    Curr Opin Hematol; 2010 Sep; 17(5):450-6. PubMed ID: 20601873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.
    Roopkumar J; Khorana AA
    Cancer Treat Res; 2019; 179():55-68. PubMed ID: 31317480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated thrombosis: updates and controversies.
    Khorana AA
    Hematology Am Soc Hematol Educ Program; 2012; 2012():626-30. PubMed ID: 23233644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients.
    Tagalakis V; Wharin C; Kahn SR
    Semin Thromb Hemost; 2013 Mar; 39(2):127-40. PubMed ID: 23386467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
    Connolly GC; Khorana AA
    Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prophylaxis of VTE in cancer outpatients.
    Imberti D; Benedetti R
    Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VTE risk assessment in cancer. Who needs prophylaxis and who does not?
    Ay C; Pabinger I
    Hamostaseologie; 2015; 35(4):319-24. PubMed ID: 25740182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism prevention in cancer outpatients.
    Khorana AA
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1431-8. PubMed ID: 24225974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.
    Dammacco F; Vacca A; Procaccio P; Ria R; Marech I; Racanelli V
    Clin Exp Med; 2013 May; 13(2):85-97. PubMed ID: 23456539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
    Barsam SJ; Patel R; Arya R
    Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
    Pabinger I; Ay C
    Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomolecular markers of cancer-associated thromboembolism.
    Hanna DL; White RH; Wun T
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):19-29. PubMed ID: 23522921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of venous thromboembolism in cancer patients.
    Frere C; Doucet L; Farge D
    Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
    Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
    J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of venous Thromboembolism in cancer: a brief review of risk-benefit approaches and guidelines' recommendations.
    Djulbegovic B
    J Support Oncol; 2010; 8(2):84-91. PubMed ID: 20464888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.